• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Windlas Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029
1,102.30 -27 (-2.40%)
  • As on 22 Sep 2026 (EOD)

  • Today’s Low

    1,092.30

  • Today’s High

    1,148.00

  • Open

    1,138.50

  • Perv Close

    1,129.40

  • 52W Low

    697.40

  • 52W High

    1,181.90

Key Indicators

  • P/E(TTM)

    34.25

  • Mar.Cap (₹Cr.)

    2,274.73

  • Div & Yield %

    0.57

  • Book Value(₹)

    281.35

  • Debt-Equity Ratio

    -2.40

  • AGM Date

    22-Sep-2026

  • EPS

    32.19

  • P/E Ratio

    34.25

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    2,274.73

  • RONW (%)

    13.66

  • ROCE (%)

    18.07

Score Board

  • Equity (₹ in Cr.)

    10.32

  • BV (₹)

    281.30

  • Sales( ₹ in Cr.)

    904.09

  • NP (in Cr.)

    66.44

  • NP Var(%)

    10.0

  • Div%

    123.0

  • CPS (₹)

    47.10

  • EPS (₹)

    32.20

  • Traded Value (₹ in Lakhs)

    2,274.83

  • 52 Week High

    1,181.90

  • 52 Week Low

    697.40

  • Price BSE

    1102.0

  • Price NSE

    1,102.00

  • Market Capital( in Cr.)

    2,274.83

  • P/C Ratio

    23.40

  • P/E Ratio

    34.20

  • Price Vs.BV

    32.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 904.09 759.88 630.96 513.08 465.93 427.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 904.09 759.88 630.96 513.08 465.93 427.60
Other Income 17.80 17.65 13.47 9.97 6.71 3.09
Stock Adjustments -7.10 21.52 -9.59 15.27 4.74 -3.67
Total Income 914.79 799.05 634.84 538.32 477.38 427.02
EXPENDITURE :            
Raw Materials 550.13 493.38 386.59 340.71 307.56 270.74
Power and Fuel Cost 28.29 21.61 16.15 12.90 11.01 11.53
Employee Cost 152.09 122.92 87.46 70.32 63.41 58.32
Other Manufacturing Expenses 9.72 11.57 10.52 8.63 8.95 8.37
Selling and Administration Expenses 45.47 33.53 35.92 30.13 23.08 15.09
Miscellaneous Expenses 6.58 4.28 6.63 5.41 3.78 37.54
Employee Benefit Expenses 152.09 122.92 87.46 70.32 63.41 58.32
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 792.29 687.29 543.27 468.10 417.78 401.60
Operating Profit 122.50 111.76 91.57 70.21 59.60 25.44
Interest 4.83 4.38 1.10 0.79 1.42 1.29
Gross Profit 117.67 107.38 90.47 69.42 58.18 24.15
Depreciation 30.74 27.99 13.44 12.36 12.15 12.97
Profit Before Tax 86.93 79.39 77.03 57.06 46.03 11.18
Current Tax 20.70 18.27 17.34 14.35 10.13 4.84
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 0.47 1.54 0.06 -2.66 1.33
Reported Net Profit 66.44 60.65 58.14 42.64 38.56 5.01
Extraordinary Items 0.00 0.01 0.00 0.65 0.01 -26.17
Adjusted Net Profit 66.44 60.64 58.14 41.99 38.55 31.18
Adjustment below Net Profit 0.11 -0.54 -0.24 -0.16 -0.18 -26.37
P & L Balance brought forward 274.90 226.29 176.70 141.84 103.46 124.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.16 11.50 8.32 7.63 0.00 0.00
P & L Balance carried down 329.29 274.90 226.29 176.70 141.84 103.46
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 123.00 116.00 110.00 80.00 70.00 0.00
Dividend Per Share(Rs) 6.30 5.80 5.50 4.00 3.50 0.00
Earnings Per Share-Unit Curr 31.48 28.94 27.96 20.38 17.69 7.81
Earnings Per Share(Adj)-Unit Curr 31.48 28.94 27.96 20.38 17.69 -
Book Value 275.20 241.31 216.51 192.42 181.30 310.39
Book Value(Adj)-Unit Curr 275.20 241.31 216.51 192.42 181.30 -

Shareholding Pattern

  • Promoter Group

    63.31%

  • Public Share Holding

    36.69%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,381,340 40.61 8,381,340 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,684,012 22.70 4,684,012 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,065,352 63.31 13,065,352 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 421,603 2.04 421,603 33
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,187,986 5.76 1,187,986 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 843,384 4.09 843,384 11
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,452,973 11.89 2,452,973 48
2] Non Institution
Bodies Corporate 278,685 1.35 278,685 174
Clearing Members 28,713 0.14 28,713 7
Directors of their Relatives 23,533 0.11 23,533 1
Employees 89,839 0.44 89,839 243
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 272,505 1.32 272,505 791
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 147,911 0.72 147,911 1,142
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 304,138 1.47 304,138 2
Individuals holding nominal share capital up to Rs. 1 lakh 3,913,694 18.97 3,913,694 42,554
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,838 0.01 2,838 2
Others 33,295 0.16 33,295 2
Sub Total 5,117,904 24.80 5,117,904 44,941
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,636,229 100.00 20,636,229 44,996

Company Background

Windlas Biotech LtdPharmaceuticals - Indian - Formulations

  • Windlas Biotech Ltd
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029

  • Incorporation Year

    2001

  • Registered Office

    40/1 Mohabewala Industrial
    Area, Dehradun,
    Uttarakhand-248110

  • Telephone

    91-135-6608000

  • FAX

  • Chairman

    Vivek Dhariwal

  • Managing Director

    Hitesh Windlass

  • Company Secretary

    Ananta Narayan Panda

  • Auditor

    J C Bhalla & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Windlas Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Windlas Biotech 1,102.35 921.89 904.09 34.25 15.81
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77